PDL1-targeted CD28 costimulatory bispecific antibodies enhance T cell activation in solid tumors.

Moore, GL; Zeng, V; Diaz, J; Bonzon, C; Avery, KN; Love, R; Dragovich, M; Rashid, R; Hackett, M; Leung, IW; Qi, J; Bakhit, CG; Muchhal, US; Barlow, NJ; Desjarlais, JR; Hedvat, M

CANCER RESEARCH, 2021; 81 (13):